In the present study, through an unbiased bioinformatic screening strategy for mitochondrial transmembrane candidates, we identified mitochondrial carrier 1 (MTCH1) as a potential mitochondrial anti-ferroptosis factor in cervical cancers. This evidence concerns the gene MTCH1 and cervical carcinoma.